bims-mricoa 2022-03-20 papers

Issue of 2022–03–20
three papers selected by
Merve Yavuz, Bilkent University

ACS Appl Bio Mater. 2022 Mar 17.

Appropriate Size of Fe3O4 Nanoparticles for Cancer Therapy by Ferroptosis.

Xiangrong Tian, Li Ruan, Shengwang Zhou, Lin Wu, Jin Cao, Xueyong Qi, Xin Zhang, Song Shen.

Iron oxide nanoparticles can induce cell death due to the ferroptosis mechanism, showing a great potential for cancer therapy. Here, we synthesized different-sized iron oxide nanoparticles (2-100 nm) to investigate their antitumor effect and toxicity mechanism. It was found that ultrasmall nanoparticles (< ∼5 nm) could accumulate in nucleus and were more efficient in triggering the generation of •OH than larger nanoparticles due to the quicker release of Fe2+, thus exhibiting more remarkable cytotoxicity. Nevertheless, 10 nm iron oxide nanoparticles group displayed the best antitumor effect in vivo. We studied the in vivo and intratumoral biodistribution of the nanoparticles and found that the therapeutic effects were related to both the tumoral accumulation and intratumoral distribution of nanoparticles. This work indicates the appropriate size of Fe3O4 NPs for cancer treatment and illustrates the possible factors that influence the therapeutic effect, suggesting the great potential of iron oxide in clinical application.

Keywords: biodistribution; cancer therapy; ferroptosis; iron oxide nanoparticles; reactive oxygen species

DOI: https://doi.org/10.1021/acsabm.2c00068

Saudi J Med Med Sci. 2022 Jan-Apr;10(1):10(1): 12-18

Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review.

Afnan Fahd Al-Muhanna.

Over the past five years, several studies have reported deposition and retention of gadolinium in the brain after administration of gadolinium-based contrast agents (GBCAs) during radiological procedures. Patients with renal insufficiency cannot filter gadolinium efficiently; however, gadolinium is also retained in the brain of some adults and pediatrics with no renal impairment. In the literature, data is mostly available from retrospective magnetic resonance imaging (MRI) studies, where gadolinium deposition may be indirectly measured by evaluating changes in T1 signal intensity in the brain tissues, particularly in the deep gray matter such as the dentate nucleus and/or globus pallidus. Many pathological studies have reported a direct correlation between T1 signal changes and gadolinium deposition in human and animal autopsy specimens, which raised concerns on the use of GBCAs, particularly with linear chelators. The association between gadolinium accumulation and occurrence of physical and neurological side effects or neurotoxic damage has not yet been conclusively demonstrated. Studies have also observed that gadolinium is deposited in the extracranial tissues, such as the liver, skin, and bone, of patients with normal kidney function. This narrative review describes the effects of different types of GBCAs in relation to gadolinium deposition, evaluates current evidence on gadolinium deposition in various tissues of the human body, and summarizes the current recommendations regarding the use of GBCAs.

Keywords: Diagnostic imaging; T1 hyperintensity; gadolinium adverse effects; gadolinium deposition; gadolinium retention; gadolinium-based contrast agents (GBCAs)

DOI: https://doi.org/10.4103/sjmms.sjmms_198_21

IET Nanobiotechnol. 2022 Mar 16.

Drug delivery and anticancer activity of biosynthesised mesoporous Fe2 O3 nanoparticles.

Firoozeh Abolhasani Zadeh, Saade Abdalkareem Jasim, Nigora E Atakhanova, Hasan Sh Majdi, Mohammed Abed Jawad, Mohammed Khudair Hasan, Fariba Borhani, Mehrdad Khatami.

Mesoporous magnetic nanoparticles of haematite were synthesised using plant extracts according to bioethics principles. The structural, physical and chemical properties of mesoporous Fe2 O3 nanoparticles synthesised with the green chemistry approach were evaluated by XRD, SEM, EDAX, BET, VSM and HRTEM analysis. Then, their toxicity against normal HUVECs and MCF7 cancer cells was evaluated by MTT assay for 48 h. These biogenic mesoporous magnetic nanoparticles have over 71% of doxorubicin loading efficiency, resulting in a 50% reduction of cancer cells at a 0.5 μg.ml-1 concentration. Therefore, it is suggested that mesoporous magnetic nanoparticles be used as a multifunctional agent in medicine (therapeutic-diagnostic). The produced mesoporous magnetic nanoparticles with its inherent structural properties such as polygonal structure (increasing surface area to particle volume) and porosity with large pore volume became a suitable substrate for loading the anti-cancer drug doxorubicin.

Keywords: MCF-7 breast cancer cell line; MTT test; bioethics principles; mesoporous magnetic nanoparticles; targeted transfer

DOI: https://doi.org/10.1049/nbt2.12080